Who
Simona Skerjanec
Director
Company insider
Files Form 4 as: Director, Immunic; Director, Atrium Therapeutics; Director, Avidity Biosciences.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 14 May 2024
- Last trade
- 5 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jul 2026filed 7 Jul 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 29 Jun 2026filed 29 Jun 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 29 Jun 2026filed 29 Jun 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,370 at $0.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | RNA Atrium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | RNA Atrium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 Feb 2026filed 27 Feb 2026 | Avidity BiosciencesBiotechnology | SEC FORM 4 Code D | —6,692 | filing |
| 27 Feb 2026filed 27 Feb 2026 | Avidity Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,034 | filing |
| 27 Feb 2026filed 27 Feb 2026 | Avidity Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —42,308 | filing |
| 27 Feb 2026filed 27 Feb 2026 | Avidity Biosciencesoption or derivative | SEC FORM 4 Code D | —10,034 | filing |
| 27 Feb 2026filed 27 Feb 2026 | Avidity Biosciencesoption or derivative | SEC FORM 4 Code D | —42,308 | filing |
| 27 Feb 2026filed 27 Feb 2026 | Avidity Biosciences | SEC FORM 4 Code D | —6,692 | filing |
| 10 Jun 2025filed 12 Jun 2025 | Avidity Biosciencesoption or derivative | SEC FORM 4 Code A | —10,034 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | Avidity Biosciences | SEC FORM 4 Code A | —6,692 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 22 Jul 2024filed 24 Jul 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 22 Jul 2024filed 24 Jul 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 14 May 2024filed 16 May 2024 | Avidity Biosciencesoption or derivative | SEC FORM 4 Code A | —42,308 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.